Imperative Care · 3 hours ago
Quality Control Technician II
Imperative Care is a company focused on improving care for patients suffering from stroke and other vascular diseases. They are seeking a Quality Control Technician II to perform inspection and testing tasks, ensuring compliance with quality control specifications and regulations.
Health CareMedicalMedical Device
Responsibilities
Conduct visual, dimensional and functional inspection, as directed by quality procedures and other specifications
Record and analyze the inspection and testing data to determine if acceptance criteria is met
Review device history records, manufacturing records, and quality control records to verify that the information is accurate and complete and that all specifications and GDP requirements have been met
Fill out, organize, reviews, maintain and archive quality control records
Qualification
Required
A minimum of 2 years of quality control experience in the medical device industry; or equivalent combination of education/training and work experience
Understanding of basic inspection techniques
Ability to describe in detail observed defects and assist in the disposition activities for nonconforming material
Must be able to read drawing schematics and tolerancing symbols
Preferred
Experience working with electrochemical capital equipment, and catheters, endovascular or neurological devices
Benefits
Stock options
Competitive salaries
Bonus
A 401k plan
Health benefits
Generous PTO
Parental leave program
Emotional health resources
Company
Imperative Care
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
H1B Sponsorship
Imperative Care has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (3)
2023 (5)
2021 (1)
Funding
Current Stage
Late StageTotal Funding
$558.97MKey Investors
Ally Bridge GroupD1 Capital Partners
2024-07-25Series E· $150M
2021-07-15Series D· $260M
2021-01-01Debt Financing· $40M
Recent News
BioWorld Financial Watch
2025-09-24
Company data provided by crunchbase